Main decisions at Global Fund’s 41st Board meeting include updated allocations methodology and restricted financial contributions
On 15-16 May 2019, the Global Fund Board held its 41st meeting in Geneva, Switzerland. GFO was present, with observer status. The main decisions made at the meeting, in chronological order, are described below.
The allocation methodology for the 2020-2022 allocation period approved by the Board at its meeting on 15-16 May looks a lot like the methodologies used for 2017-2019 and 2014-2016. For the most part, the changes were relatively minor. The only significant change involved refinements to the disease burden indicators for malaria for the allocation formula (see below).
At its meeting on 15–16 May 2019, the Global Fund Board is expected to adopt a methodology for use in determining the 2020–2022 allocations. The Board is also expected to adopt measures designed to strengthen the process of selecting members for the Board’s standing committees.
The Global Fund’s Technical Evaluation Reference Group (TERG), the Technical Review Panel (TRP) and the Secretariat have jointly concluded that the allocation methodology used for 2017–2019 “is effectively delivering on its objectives by increasing funds to countries of higher burden and lower economic capacity while accounting for populations disproportionately affected by the three diseases.”
Le Fonds mondial devrait aligner ses investissements à effet catalyseur aux objectifs mondiaux pour l'éradication du paludisme
En 2015, l'Organisation mondiale de la santé (OMS) indiquait que plus de la moitié des 106 pays où le paludisme continuait à se transmettre en 2000, avait réussi à faire baisser l’apparition de nouveaux cas d’au moins 75 %. Les investissements du Fonds mondial ont été, et continuent d'être, un facteur clé de ce succès.
The Global Fund should align its catalytic investments with global targets for malaria elimination and eradication
In 2015, the World Health Organization (WHO) reported that among the 106 countries with malaria transmission in 2000, more than half had achieved at least a 75% reduction in new cases. The Global Fund’s investments have been, and continue to be, a key driver of this success. Dedicated funding for malaria has dramatically reduced the malaria burden and sustained these reductions.